Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone prolonged-release plus naloxone ratio-finding study in opioid-induced constipation
2008-005315-18Phase 3Completed
- Sponsor
- Mundipharma Research
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic pain comparing Hydromorphone + naloxone combination arm(s), Hydromorphone alone active control and Placebo control (3 arms). Primary endpoints: Optimal hydromorphone prolonged-release to naloxone ratio, Analgesic efficacy and 1 more. Started May 2009; status: completed.
02
Drugs
hydromorphonenaloxone
03
Conditions
chronic pain
Beyond the preview
Go deeper on 2008-005315-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005315-18.